Loading asset research
Alaunos Therapeutics Inc. Common Stock
TCRTNasdaq · USD · StocksQuote as of · Exchange session not verified$1.51
-3.21%
Today
TCRT
Loading 1D prices…
Market cap
$3.8M
Volume
18.2K
52w high
$4.5952w low
$1.50Company profile
Alaunos Therapeutics Inc. Common Stock
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Fort Lauderdale, FL, United States
Employees
1
Fiscal year end
1231
CIK
1107421
Session & valuation
Open$1.52
Previous close$1.56
Day high$1.53
Day low$1.50
30-day avg. volume11.5K
Outstanding shares2.5M
Diluted EPS-$2.20
Latest annual period
P/E (trailing)-0.69
P/E (forward)-2.52
Price / book2.79
Beta-0.97
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| MBIOMustang Bio Inc. Common Stock | $3.8M | $0.00 | — | -$0.39 | -2.50% | Unrated |
| CVKDCadrenal Therapeutics Inc. Common Stock | $3.9M | $0.00 | — | -$6.64 | -7.63% | Buy |
| RDHLRedhill Biopharma Ltd. American Depositary Shares | $3.9M | $286K | -150.00% | $0.00 | -1.23% | Unrated |
| REVBRevelation Biosciences Inc. Common Stock | $4M | $0.00 | — | -$23.95 | -0.70% | Buy |
| SILOSilo Pharma Inc. Common Stock | $3.7M | $72.1K | -5863.50% | -$0.50 | -0.19% | Unrated |